Orange Book product · Generic (ANDA)
LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE
At a glance
Apr 02, 2025
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Apr 02, 2025
1 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
LIDOCAINE HYDROCHLORIDE
Strength
1%
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 219535
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of LIDOCAINE HYDROCHLORIDE
- 2008AKTENBrand (NDA)
NDA 022221 · THEA PHARMA
- —LIDOCAINE HYDROCHLORIDEBrand (NDA)
NDA 017508 · ABRAXIS PHARM
- —LIDOCAINE HYDROCHLORIDEBrand (NDA)
NDA 017701 · INTL MEDICATION
- —LIDOCAINE HYDROCHLORIDEBrand (NDA)
NDA 018543 · INTL MEDICATION
- 2026LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 220071 · VIWIT PHARM
- 2023LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217693 · MANKIND PHARMA
- 2023LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217692 · MANKIND PHARMA
- 2022LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215132 · AFAXYS
- 2021LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214336 · ASPIRO
- 2021LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 214339 · ASPIRO
- 2020LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 212821 · HUONS
- 2018LIDOCAINE HYDROCHLORIDEGeneric (ANDA)
ANDA 208474 · B BRAUN MEDICAL
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
